Evidence map›Paper›PMID 28970402›Full record

ArticlePharmacy (Basel, Switzerland)2016

Perception of the Professional Knowledge of and Education on the Medical Technology Products among the Pharmacists in the Baltic and Nordic Countries-A Cross-Sectional Exploratory Study.

Daisy Volmer, Aleksandra Sokirskaja, Raisa Laaksonen, Kirsti Vainio, Niklas Sandler, Kjell H Halvorsen, Reidun Lisbet Skeide Kjome, Sveinbjörn Gizurarson, Ruta Muceniece, Baiba Maurina and 5 more

Abstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Daisy VolmerInstitute of Pharmacy, Faculty of Medicine, University of Tartu, 1 Nooruse Str., 50411 Tartu, Estonia. daisy.volmer@ut.ee.ORCID 0000-0001-6742-5044
Aleksandra SokirskajaInstitute of Pharmacy, Faculty of Medicine, University of Tartu, 1 Nooruse Str., 50411 Tartu, Estonia. sokirskaja@hot.ee.
Raisa LaaksonenDivision of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Viikinkaari 9 (P.O. Box 56), 00014 Helsinki, Finland. raisa.laaksonen@helsinki.fi.
Kirsti VainioSchool of Pharmacy, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland. kirsti.vainio@uef.fi.
Niklas SandlerPharmaceutical Sciences, Åbo Akademi University, BioCity, Artillerigatan 6A FI, 20520 Turku, Finland. niklas.sandler@abo.fi.
Kjell H HalvorsenDepartment of Pharmacy, Faculty of Health Science, UiT The Arctic University of Norway, 9037 Tromsø, Norway. kjell.h.halvorsen@uit.no.ORCID 0000-0003-1562-1822
Reidun Lisbet Skeide KjomeDepartment of Global Public Health and Primary Care, University of Bergen, 5018 Bergen, Norway. reidun.kjome@isf.uib.no.
Sveinbjörn GizurarsonFaculty of Pharmaceutical Sciences, University of Iceland, 107 Reykjavik, Iceland. sveinbj@hi.is.
Ruta MucenieceDepartment of Pharmacy, Faculty of Medicine, University of Latvia, LV-1050 Riga, Latvia. ruta.muceniece@lu.lv.
Baiba MaurinaFaculty of Pharmacy, Riga Stradins University, LV-1007 Riga, Latvia. Baiba.Maurina@rsu.lv.
Jurgita DauksieneDepartment of Drug Technology and Social Pharmacy, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania. jurgita.dauksiene@gmail.com.
Lilian RuubenTallinn Health Care College, 13418 Tallinn, Estonia. lilian.ruuben@ttk.ee.
Ingunn BjörnsdottirSchool of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway. ingunn.bjornsdottir@gmail.com.
Tagne RatasseppMedical Device Department, Estonian Health Board, 50303 Tartu, Estonia. Tagne.Ratassepp@terviseamet.ee.
Jyrki HeinämäkiInstitute of Pharmacy, Faculty of Medicine, University of Tartu, 1 Nooruse Str., 50411 Tartu, Estonia. jyrki.heinamaki@ut.ee.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With increased development of medical technology (MT), new challenges emerge related to education and training of pharmacists and other healthcare specialists. Currently, only a few universities in the EU promote MT education and research.

objectivesThe aim of this study was to evaluate the current status, views on, and need for the education on MT for the pharmacy students and practicing pharmacists in the Baltic and Nordic countries.

methodsThe representatives of higher education institutions and community/hospital pharmacists from six Baltic and Nordic countries participated in a qualitative cross-sectional exploratory internet-based study from May to October 2014.

resultsApproximately two-third of the respondents considered professional knowledge about MT products important for pharmacists, but half of them had never participated in any MT courses. More practicing pharmacists than representatives of academia underlined the need for increased MT education for pharmacy students in the future.

conclusionsThe pharmacists in the Baltic and Nordic countries consider the professional knowledge about MT as pertinent in their education and work. The limited number and status of MT courses available today, however, is a major concern among both pharmacy students and practicing pharmacists in these countries. In the future, increasing education combining theory and practice about MT products would be one possible solution to overcome this challenge.

Indexed as

educationmedical technologypharmacy studentspracticing pharmacistsprofessional competency

Identifiers

PMID28970402
PMCPMC5419374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.